Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025
On Friday, November 14, 2025, Cytek Biosciences, Inc. (NASDAQ: CTKB) is trading sharply higher, extending a strong two‑week run helped by fresh industry recognition, product awards and steady (if modest) earnings growth. As of the latest trade this afternoon, CTKB is changing hands around $4.99, up roughly 9% intraday, with the stock appearing on Nasdaq’s list of notable movers even as the broader U.S. market trades lower.Benzinga Below is a breakdown of all the key Cytek‑related news impacting CTKB today, November 14, 2025, plus the most important headlines from the past few days that are driving sentiment. 1. What’s New
